Prof. Merav Lidar, MD, MSc is a senior rheumatologist and Director of the Center for Autoimmune Diseases and the Department of Rheumatology at Sheba Medical Center.
She is a global pioneer in applying CAR-T cell therapy to treat severe autoimmune diseases, including lupus, vasculitis, rheumatoid arthritis, and rare genetic inflammatory syndromes.
Since 2020, Prof. Lidar has led Sheba’s clinical and research program for CAR-T in autoimmune conditions, offering new hope to patients who have failed all conventional treatments.
In 2025, she co-authored a groundbreaking study demonstrating the safety and efficacy of CD19-directed CAR-T therapy for refractory rheumatoid arthritis, positioning Sheba among the first centers globally to report successful use of CAR-T in autoimmune patients.
Prof. Lidar Presents on CAR-T Therapy for Rheumatologic Diseases
Prof. Lidar earned her medical degree and MSc from Tel Aviv University, where she now serves as a faculty member. She also chairs the National Rheumatology Residency Committee and is a member of the Israel Society of Rheumatology and the American College of Rheumatology. In addition to her clinical leadership, she has authored numerous peer-reviewed articles and serves as principal investigator in multiple clinical trials exploring novel biologic and genetic therapies.
Prof. Lidar Presents on CAR-T Therapy for Rheumatologic Diseases
At Israeli Hospitals Ltd., we assist patients in accessing CAR-T therapy for autoimmune diseases in Israel. We handle the process from start to finish, including eligibility review, and providing full logistical support during their stay.
If you are searching for advanced treatment options for a complex autoimmune disease, Prof. Merav Lidar is one of the world’s leading experts.
Prof. Lidar Presents on CAR-T Therapy for Rheumatologic Diseases
